Hwang, K., Kim, T. M., Park, C., Chang, J. H., Jung, T., Kim, J. H., . . . Kim, C. (2020). Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study). Cancer Res Treat.
Citação norma ChicagoHwang, Kihwan, et al. "Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas Without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)." Cancer Res Treat 2020.
Citação norma MLAHwang, Kihwan, et al. "Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas Without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)." Cancer Res Treat 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.